Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United Statesroswellpark.org ↗
- Ownership
- Private
- Employees
- ~4244
- Development stage
- Commercial
01
Overview
Roswell Park is a comprehensive cancer center providing advanced treatment for all forms of adult and pediatric cancer. It conducts clinical research and develops new therapies that improve cancer survival rates. In 2017, it launched the world's first clinical trial using a two-gene combination for adoptive T-cell therapy.
- Therapeutic areas
- OncologyHematology
- Modalities
- ImmunotherapyAdoptive T-cell therapyTherapeutic vaccinesPhotodynamic therapy
- Industry
- Academic Hospital/University/Research
02
Partnerships
BridgeBio Pharma, Inc.John R. Oishei Children's Hospital of Buffalo
Beyond the preview
Go deeper on Roswell Park Comprehensive Cancer Center.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Roswell Park Comprehensive Cancer Center.